New article posted at Seeking Alpha:
Dendreon Gets European Recommendation
See also my: Q1 2013 Dendreon Analyst Conference Notes
Provenge is approved in the United States for the treatment of metastatic minimally symptomatic castrate-resistant prostate cancer. Dendreon is seeking approval for Provenge in Europe.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment